Safety and tolerability of four ascending single doses of transgenic sheep derived human alpha-1-antitrypsin (tg-hAAT) administered by a nebuliser to patients with cystic fibrosis(CF).

Lorraine Martin, M. Pasteur, M. Keogan, Joseph Elborn, S. Buckingham, D. Bilton, J. Edgar

Research output: Contribution to conferencePaperpeer-review

Original languageEnglish
PagesA191-A191
Number of pages1
Publication statusPublished - Mar 1999
EventAmerican Thoracic Society Conference - San Diego, CA, United States
Duration: 07 Apr 199910 Apr 1999

Conference

ConferenceAmerican Thoracic Society Conference
CountryUnited States
CitySan Diego, CA
Period07/04/199910/04/1999

Bibliographical note

Published in the American Journal of Respiratory and Critical Care Medicine

Cite this